Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03306407
Other study ID # LEK EKNZ 2015-271
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2015
Est. completion date July 2018

Study information

Verified date October 2018
Source Swiss Tropical & Public Health Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Travelling to tropical and subtropical countries is a known risk factor for becoming colonized with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. Especially travellers returning from the Indian subcontinent show high colonization rates of up to almost 90%.

While risk factors for becoming colonized have been identified in several studies, no preventive measure has been tested so far.

One of the factors associated with becoming colonized while travelling is suffering from travellers' diarrhoea. Earlier studies looking at diarrhoea in childhood as well as school and/or work absenteeism because of diarrhoeal diseases have shown protective effects through good hand hygiene. Furthermore, a recent retrospective study has shown lower rates of travellers' diarrhoea in people using hand gel sanitizers. Improving hand hygiene in travellers through increased hand washing and the use of hand gel sanitizers might therefore not only decrease the rate of travellers' diarrhoea but the carriage rate with ESBL-producing Enterobacteriaceae as well. However, there is no prospective data available to prove the usefulness of such an intervention, neither in the prevention of travellers' diarrhoea nor in the prevention of colonization.

In the current study, investigators plan to compare colonization rates with ESBL-producing Enterobacteriaceae in travellers receiving pre-travel advice on improved hand hygiene (including the use of hand gel sanitizers) with travelers receiving standard advice.


Recruitment information / eligibility

Status Completed
Enrollment 290
Est. completion date July 2018
Est. primary completion date July 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age > 18 years

- travelling to the Indian subcontinent (India, Bhutan and/or Nepal) for up to 4 weeks

Exclusion Criteria:

- age < 18 years

- travelling to other destinations than India, Bhutan and/or Nepal

- antibiotic treatment at the time of the first sampling

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Improved hand hygiene
The intervention group receives pre-travel advice with a special focus on improved hand hygiene including the use of hand gel sanitizer (Hartmann Sterillium) (bundle intervention)

Locations

Country Name City State
Switzerland Swiss Tropical and Public Health Institute Basel
Switzerland Epidemiology, Biostatistics and Prevention Institute Zurich

Sponsors (2)

Lead Sponsor Collaborator
Christoph Hatz University of Zurich

Country where clinical trial is conducted

Switzerland, 

References & Publications (4)

Henriey D, Delmont J, Gautret P. Does the use of alcohol-based hand gel sanitizer reduce travellers' diarrhea and gastrointestinal upset?: A preliminary survey. Travel Med Infect Dis. 2014 Sep-Oct;12(5):494-8. doi: 10.1016/j.tmaid.2014.07.002. Epub 2014 Jul 11. — View Citation

Kantele A, Lääveri T, Mero S, Vilkman K, Pakkanen SH, Ollgren J, Antikainen J, Kirveskari J. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015 Mar 15;60(6):837-46. doi: 10.1093/cid/ciu957. Epub 2015 Jan 21. — View Citation

Kuenzli E, Jaeger VK, Frei R, Neumayr A, DeCrom S, Haller S, Blum J, Widmer AF, Furrer H, Battegay M, Endimiani A, Hatz C. High colonization rates of extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis. 2014 Oct 1;14:528. doi: 10.1186/1471-2334-14-528. — View Citation

Paltansing S, Vlot JA, Kraakman ME, Mesman R, Bruijning ML, Bernards AT, Visser LG, Veldkamp KE. Extended-spectrum ß-lactamase-producing enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis. 2013 Aug;19(8):1206-13. doi: 10.3201/eid.1908.130257. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Colonization rates with ESBL-producing Enterobacteriaceae in travellers returning from South Asia Coloinzation rates with ESBL-producing Enterobacteriaceae in travellers up to 1 week after travel
Secondary Incidence of travellers' diarrhoea (during and up to 2 weeks after travelling, assessed through self-reporting) Incidence of travellers' diarrhoe up to 2 weeks after travel
See also
  Status Clinical Trial Phase
Completed NCT03339947 - French Travelers' Knowledge of Risk of Acquiring ESBL-PE N/A
Completed NCT02625129 - Effectiveness of and Satisfaction With a Pharmacist-managed Travel Medicine Clinic N/A